Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Barbara Danzer"'
Autor:
Barbara Danzer, Mateo Jukic, Andreas Dunkel, Gaby Andersen, Barbara Lieder, Erika Schaudy, Sarah Stadlmayr, Jory Lietard, Timm Michel, Dietmar Krautwurst, Bernhard Haller, Percy Knolle, Mark Somoza, Paul Lingor, Veronika Somoza
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Chemosensory impairment is an outstanding symptom of SARS-CoV-2 infections. We hypothesized that measured sensory impairments are accompanied by transcriptomic changes in the foliate papillae area of the tongue. Hospital personnel with known
Externí odkaz:
https://doaj.org/article/795f6bff95bc41ffb3cabfc0eab965dd
Autor:
Christina Pfab, Anush Abgaryan, Barbara Danzer, Fatme Mourtada, Weaam Ali, André Gessner, Nahed El-Najjar
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Drug-drug interaction (DDI), which can occur at the pharmacokinetics and/or the pharmacodynamics (PD) levels, can increase or decrease the therapeutic or adverse response of a drug itself or a combination of drugs. Cancer patients
Externí odkaz:
https://doaj.org/article/86c5e6b0e2a440068e3bb17de3ab33f3
Publikováno v:
Biomarker Insights, Vol 12 (2017)
Objective: The aim of the study was to define pharmacodynamic markers for sudemycin D6, an experimental cancer drug that changes alternative splicing in human blood. Methods: Blood samples from 12 donors were incubated with sudemycin D6 for up to 24
Externí odkaz:
https://doaj.org/article/0e3e2d154817425c893a03e142c2444e
Publikováno v:
Biomarker Insights
Biomarker Insights, Vol 12 (2017)
Biomarker Insights, Vol 12 (2017)
Objective: The aim of the study was to define pharmacodynamic markers for sudemycin D6, an experimental cancer drug that changes alternative splicing in human blood. Methods: Blood samples from 12 donors were incubated with sudemycin D6 for up to 24